1. EachPod

ReachMD CME - Podcast

ReachMD CME

 ReachMD

Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, cardiology, women's health and more. And our CME library is continuously growing, every quarter.

Health Medicine Science & Medicine
Update frequency
every day
Episodes
499
Years Active
2019 - 2025
Share to:
ARVO Recap: What’s New in TED

ARVO Recap: What’s New in TED

CME credits: 1.00
Valid until: 30-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/arvo-recap-whats-new-in-ted/26964/

Thyroid eye disease (TED) is a relatively rare disease …

Mon 30 Sep 2024
Diagnostic Challenges of TED: What General Eye Care Providers Need to Know

Diagnostic Challenges of TED: What General Eye Care Providers Need to Know

CME credits: 1.00
Valid until: 30-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-challenges-of-ted-what-general-eye-care-providers-need-to-know/26960/

Thyroid e…

Mon 30 Sep 2024
Diagnostic Challenges of TED: What Eye Care Specialists Need to Know

Diagnostic Challenges of TED: What Eye Care Specialists Need to Know

CME credits: 1.00
Valid until: 30-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/diagnostic-challenges-of-ted-what-eye-care-specialists-need-to-know/26961/

Thyroid eye dis…

Mon 30 Sep 2024
TED: Current Treatments, Current Challenges

TED: Current Treatments, Current Challenges

CME credits: 1.00
Valid until: 30-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/ted-current-treatments-current-challenges/26962/

Thyroid eye disease (TED) is a relatively…

Mon 30 Sep 2024
TED: Clinical Trials Spotlight

TED: Clinical Trials Spotlight

CME credits: 1.00
Valid until: 30-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/ted-clinical-trials-spotlight/26965/

Thyroid eye disease (TED) is a relatively rare diseas…

Mon 30 Sep 2024
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer

Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer

Mon 30 Sep 2024
Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management

Mastering the Complexity of AML Treatment: A Multidimensional Approach to Diagnosis, Therapy, and Side Effect Management

Wed 25 Sep 2024
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy

Wed 25 Sep 2024
Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Noncovalent BTK Inhibitors: New Targeted Options for Relapsed or Refractory Chronic Lymphocytic Leukemia and Mantle Cell Lymphoma

Tue 24 Sep 2024
Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management

Warm Autoimmune Hemolytic Anemia: How Antibody-Based Therapies Are Revolutionizing Its Management

Wed 18 Sep 2024
HF Management for Patients with Comorbid Conditions

HF Management for Patients with Comorbid Conditions

CME credits: 0.75
Valid until: 15-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/hf-management-for-patients-with-comorbid-conditions/27020/

Heart failure (HF) represents a…

Mon 16 Sep 2024
Level Up Your Skills: Tailoring Management of HF

Level Up Your Skills: Tailoring Management of HF

CME credits: 0.75
Valid until: 15-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/level-up-your-skills-tailoring-management-of-hf/27021/

Heart failure (HF) represents a sig…

Mon 16 Sep 2024
Partnering with Patients: Building Effective Communication and Support in HF Care

Partnering with Patients: Building Effective Communication and Support in HF Care

Mon 16 Sep 2024
Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression

Earlier is Better: Identifying and Diagnosing HF Early in Disease Progression

Mon 16 Sep 2024
A Practical Guide to Prescribing in HF

A Practical Guide to Prescribing in HF

CME credits: 0.75
Valid until: 15-09-2025
Claim your CME credit at https://reachmd.com/programs/cme/a-practical-guide-to-prescribing-in-hf/27019/

Heart failure (HF) represents a significant …

Mon 16 Sep 2024
Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting

Targeting Resistance in EGFRm NSCLC with HER3-Directed ADCs in the Community Setting

Fri 13 Sep 2024
Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors

Pivotal Data on Targeting HER2 in HER2-Expressing Solid Tumors

CME credits: 0.75
Valid until: 30-08-2025
Claim your CME credit at https://reachmd.com/programs/cme/pivotal-data-on-targeting-her2-in-her2-expressing-solid-tumors/26791/

This online MinuteCE…

Fri 30 Aug 2024
Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?

Patient Case: How Do HER2-Directed Therapies Fit Into the Ovarian Cancer Treatment Landscape?

Fri 30 Aug 2024
HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps

HER2 Testing Strategies Across Tumor Types Amidst Guidelines Gaps

CME credits: 0.75
Valid until: 30-08-2025
Claim your CME credit at https://reachmd.com/programs/cme/her2-testing-strategies-across-tumor-types-amidst-guidelines-gaps/26789/

This online Minut…

Fri 30 Aug 2024
Significance of HER2 Expression in Solid Tumors

Significance of HER2 Expression in Solid Tumors

CME credits: 0.75
Valid until: 30-08-2025
Claim your CME credit at https://reachmd.com/programs/cme/significance-of-her2-expression-in-solid-tumors/26788/

This online MinuteCE program delves…

Fri 30 Aug 2024
Disclaimer: The podcast and artwork embedded on this page are the property of ReachMD. This content is not affiliated with or endorsed by eachpod.com.